The PLD1 gene gives cells instructions for an enzyme that helps turn parts of the cell membrane into signals used for growth, movement, and normal organ development. This gene plays an important role in how the developing heart forms, especially its valves and nearby structures. If PLD1 does not work properly, rare disruptive variants can lead to congenital heart conditions, often affecting blood flow on the right side of the heart. In some families, changes in both copies of the PLD1 gene are linked to these birth differences.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do much of the work. Others mainly help regulate when certain processes take place, where they occur, and how strongly they operate. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
PLD1Gene function
What if the gene works
The PLD1 gene helps cells remodel their membranes and make signaling fats. This supports cell movement, membrane transport, and platelet function.
Risk
What if the gene does not work
More disruptive variants in the PLD1 gene are linked to congenital heart valve problems, especially on the right side of the heart. Effects can range from milder valve narrowing to more complex defects that show up before or soon after birth.
Treatment
What does that mean for your treatment
No treatment or management approach is currently tailored specifically to pathogenic variants in the PLD1 gene. The PLD1 gene is being studied as a possible drug target in cancer and blood clotting pathways, but this has not yet changed routine clinical care.
Gene function
What if the gene works
PLD1 gene function centers on how cells shape their membranes and send internal signals. It helps produce phosphatidic acid, a signaling lipid (a fat-like molecule cells use for messages), from membrane material. This supports everyday tasks such as moving tiny cargo packets, merging membranes, and organizing cell responses.
The PLD1 gene helps cells produce phosphatidic acid, a signaling lipid that helps pass messages inside the cell. This molecule can switch on pathways that guide routine cell activity.
Its protein changes part of the cell membrane so the membrane can bend, bud, or fuse when needed. That makes it easier for cells to reshape small membrane pockets and connections.
Cells use PLD1 during vesicle traffic, the movement of tiny membrane packages inside the cell. This helps proteins and other materials get to the right place at the right time.
PLD1 works in signaling networks that respond to outside cues such as growth signals. This helps cells adjust movement, secretion, and other day to day tasks in an organized way.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In discussions of how PLD1 gene variants affect protein function, the main pattern is a drop in the amount or activity of the phospholipase D1 protein. Some variants change a single building block and may partly weaken protein folding, stability, or key contact sites, while more disruptive variants can stop the protein from being made or leave it with little to no enzyme activity. This loss of function can range from mild to severe and, in people with disease-causing PLD1 variants, often tracks with how early and how strongly related heart valve features appear.
How variants are linked to conditions
When a person inherits disease-causing variants in both copies of the PLD1 gene, this can cause certain congenital heart conditions. PLD1 gene variants linked to congenital heart disease are most often associated with severe valve problems and complex right-sided heart defects present at birth, including pulmonary atresia and tricuspid valve abnormalities. The exact heart findings can vary from one person to another.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen across the general population. Most do not directly affect health and simply reflect natural human variation. For many genes, a variant associated with a condition signals a possible link rather than a certain diagnosis, particularly when several genes and environmental influences are involved. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the PLD1 gene. For many living with a PLD1 change, risk depends mostly on the exact variant and family history rather than clear day-to-day factors, and a doctor or genetic counselor can help explain personal risk.
Inheritance of PLD1 variants
For families asking about the PLD1 inheritance pattern, disease-causing variants in the PLD1 gene are inherited in an autosomal recessive way. This means a child usually inherits one PLD1 variant from each parent. Parents who each carry one variant are typically unaffected, but with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. Sons and daughters are affected at the same rate.
What does my PLD1 result mean for my family?
For families with a disease-causing change in the PLD1 gene, the pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also be carriers, and in some families a sibling could also be affected, especially when both parents carry a changed copy. Other relatives may want to learn whether they carry the same change if a PLD1-related heart condition has been found in the family.
Genetic information
Genetic testing
How you find out about variants
PLD1 genetic testing checks your DNA, usually from a blood sample or saliva, to see whether the PLD1 gene carries a variant. A lab reads the gene’s code and compares it with the usual sequence. Results may identify a variant linked with a condition related to the PLD1 gene or show no relevant change.
When should I consider getting a genetic test?
Consider PLD1 testing when a baby or child has certain serious heart problems present at birth, especially changes affecting the right side of the heart or the heart valves, or when similar heart conditions run in the family. Testing can help show whether an inherited PLD1 change is part of the cause.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but the amount they reveal depends on the condition and the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and is most helpful when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are better informed and more individualized. If you want to explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the PLD1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices or predicting medicine response. Questions about side effects, unexpected reactions, or concerns when starting, stopping, or changing treatment are best discussed with your doctor.
History
Research on phospholipase D enzymes expanded in the late 20th century as scientists worked to map how cells send internal signals. In the 1990s, researchers identified the PLD1 gene as one of the main human genes in this family, helping separate it from the closely related PLD2 gene. Initially understood only through enzyme activity seen in laboratory studies, later recognized as tied to a specific gene, PLD1 became part of a broader shift toward gene-based cell biology. From these first observations, research expanded steadily. Studies in the years that followed linked PLD1 to membrane traffic, immune cell activity, and cancer biology, which kept it relevant in basic and medical research. Today, PLD1 is mainly known within laboratory and clinical science rather than public health campaigns.